77.00 USD
↗ 0.01 (0.01%)LIVE (AS OF 07:31 PM EDT)
Forte Biosciences, Inc. Common Stock
FBRXNASDAQ • USD
Market: OPEN
Forte Biosciences, Inc. Common Stock (FBRX) trades at $77.00 per share. The technical outlook is "Buy" and the fundamental picture shows "Neutral". This is driven by a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bullish Golden Cross on the moving averages and bullish moving average alignment. On the valuation front, FBRX trades at elevated multiples relative to its peers, earning a "Richly Valued" assessment.
Technical & fundamental data as of Aug 26, 2026.
Open?$76.97
High?$77.00
Low?$75.70
Prev. Close?$76.99
Volume?1.4M
Avg. Volume?2.1M
VWAP?$76.98
Rel. Volume?0.64x
Bid / Ask
Bid?$76.97 × 1.0K
Ask?$77.00 × 900
Spread?$0.03
Midpoint?$76.99
Valuation & Ratios
Market Cap?1.6B
Shares Out?21.2M
Float?16.6M
Float %?80.9%
P/E Ratio?N/A
P/B Ratio?8.89
EPS?-$4.14
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Forte Biosciences Inc is a clinical-stage biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary anti-CD122 monoclonal antibody therapeutic candidate with potentially broad autoimmune and autoimmune-related indications. The Company is also advancing clinical development of FB102 in patient-based trials for non-segmental vitiligo and alopecia areata.
Themes
Employees
23
Market Cap
1.6B
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2020-06-16
Address
3060 PEGASUS PARK DRIVE
DALLAS, TX 75247
Phone: (310) 618-6994
DALLAS, TX 75247
Phone: (310) 618-6994
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+1/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Golden Alignment
Full Technical Analysis →Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?100
Momentum?50
Short Sent.?78
Piotroski F-Score?0/9Weak
Altman Z-Score?42.47Safe
Confidence?48%Low
Short InterestElevated
Short % of Float?9.85%Elevated
Short Interest?1.6M
Days to Cover?1.5
Free Float16.6M
Avg Daily Volume1.1M
Settlement Date2026-08-14
Financial Health
Current Ratio?10.01Strong
Quick Ratio?10.01Strong
Cash Ratio?2.45Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score67/100
P/E?N/A▾
P/B?8.89HIGH▾
Peers100
S&P21
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-17.6CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-47.9%WEAK▾
S&P3
ROA?-42.7%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-72031000
Enterprise Value?$1.6B
Fundamentals ratios updated end of day